These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 7477878)

  • 1. Preproenkephalin and preprotachykinin messenger RNA expression in normal human basal ganglia and in Parkinson's disease.
    Nisbet AP; Foster OJ; Kingsbury A; Eve DJ; Daniel SE; Marsden CD; Lees AJ
    Neuroscience; 1995 May; 66(2):361-76. PubMed ID: 7477878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of L-DOPA on preproenkephalin and preprotachykinin gene expression in the MPTP-treated monkey striatum.
    Herrero MT; Augood SJ; Hirsch EC; Javoy-Agid F; Luquin MR; Agid Y; Obeso JA; Emson PC
    Neuroscience; 1995 Oct; 68(4):1189-98. PubMed ID: 8544992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preferential loss of preproenkephalin versus preprotachykinin neurons from the striatum of Huntington's disease patients.
    Richfield EK; Maguire-Zeiss KA; Vonkeman HE; Voorn P
    Ann Neurol; 1995 Dec; 38(6):852-61. PubMed ID: 8526457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropeptide messenger RNA expression in the 6-hydroxydopamine-lesioned rat striatum reinnervated by fetal dopaminergic transplants: differential effects of the grafts on preproenkephalin, preprotachykinin and prodynorphin messenger RNA levels.
    Cenci MA; Campbell K; Björklund A
    Neuroscience; 1993 Nov; 57(2):275-96. PubMed ID: 8115038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine-opiate interaction in the regulation of neostriatal and pallidal neuronal activity as assessed by opioid precursor peptides and glutamate decarboxylase messenger RNA expression.
    Mavridis M; Besson MJ
    Neuroscience; 1999; 92(3):945-66. PubMed ID: 10426535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential regulation of neuropeptide mRNA expression in intrastriatal striatal transplants by host dopaminergic afferents.
    Campbell K; Wictorin K; Björklund A
    Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10489-93. PubMed ID: 1438238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partial reversal of increased preproenkephalin messenger ribonucleic acid (mRNA) and decreased preprotachykinin mRNA by foetal dopamine cells in unilateral 6-hydroxydopamine-lesioned rat striatum parallels functional recovery.
    Zeng BY; Jenner P; Marsden CD
    Mov Disord; 1996 Jan; 11(1):43-52. PubMed ID: 8771066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic L-DOPA treatment differentially regulates gene expression of glutamate decarboxylase, preproenkephalin and preprotachykinin in the striatum of 6-hydroxydopamine-lesioned rat.
    Zeng BY; Jolkkonen J; Jenner P; Marsden CD
    Neuroscience; 1995 May; 66(1):19-28. PubMed ID: 7637869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of repeated L-DOPA, bromocriptine, or lisuride administration on preproenkephalin-A and preproenkephalin-B mRNA levels in the striatum of the 6-hydroxydopamine-lesioned rat.
    Henry B; Crossman AR; Brotchie JM
    Exp Neurol; 1999 Feb; 155(2):204-20. PubMed ID: 10072296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic blockade of muscarinic cholinergic receptors by systemic trihexyphenidyl (Artane) administration modulates but does not mediate the dopaminergic regulation of striatal prepropeptide messenger RNA expression.
    Mavridis M; Rogard M; Besson MJ
    Neuroscience; 1995 May; 66(1):37-53. PubMed ID: 7637873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thalamo-striatal deafferentation affects preproenkephalin but not preprotachykinin gene expression in the rat striatum.
    Salin P; Kachidian P
    Brain Res Mol Brain Res; 1998 Jun; 57(2):257-65. PubMed ID: 9675424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further characterization of preproenkephalin mRNA-containing cells in the rodent globus pallidus.
    Hoover BR; Marshall JF
    Neuroscience; 2002; 111(1):111-25. PubMed ID: 11955716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neonatal dopamine depletion reveals a synergistic mechanism of mRNA regulation that is mediated by dopamine(D1) and serotonin(2) receptors and is targeted to tachykinin neurons of the dorsomedial striatum.
    Campbell BM; Gresch PJ; Walker PD
    Neuroscience; 2001; 105(3):671-80. PubMed ID: 11516832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of D1 receptor, D2 receptor, substance P and enkephalin messenger RNAs in the neurons projecting from the nucleus accumbens.
    Lu XY; Ghasemzadeh MB; Kalivas PW
    Neuroscience; 1998 Feb; 82(3):767-80. PubMed ID: 9483534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutamate decarboxylase-67 messenger RNA expression in normal human basal ganglia and in Parkinson's disease.
    Nisbet AP; Eve DJ; Kingsbury AE; Daniel SE; Marsden CD; Lees AJ; Foster OJ
    Neuroscience; 1996 Nov; 75(2):389-406. PubMed ID: 8931005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction in the ratio of beta-preprotachykinin to preproenkephalin messenger RNA expression in postmortem human putamen during aging and in patients with status lacunaris. Implications for the susceptibility to parkinsonism.
    Tohgi H; Utsugisawa K; Yoshimura M; Yamagata M; Nagane Y; Saitoh K
    Brain Res; 1997 Sep; 768(1-2):86-90. PubMed ID: 9369304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin-2 receptor stimulation normalizes striatal preprotachykinin messenger RNA in an animal model of Parkinson's disease.
    Gresch PJ; Walker PD
    Neuroscience; 1999; 93(3):831-41. PubMed ID: 10473249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deep brain stimulation of the center median-parafascicular complex of the thalamus has efficient anti-parkinsonian action associated with widespread cellular responses in the basal ganglia network in a rat model of Parkinson's disease.
    Jouve L; Salin P; Melon C; Kerkerian-Le Goff L
    J Neurosci; 2010 Jul; 30(29):9919-28. PubMed ID: 20660274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increase of preproenkephalin mRNA levels in the putamen of Parkinson disease patients with levodopa-induced dyskinesias.
    Calon F; Birdi S; Rajput AH; Hornykiewicz O; Bédard PJ; Di Paolo T
    J Neuropathol Exp Neurol; 2002 Feb; 61(2):186-96. PubMed ID: 11853020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Striatal preprotachykinin and preproenkephalin mRNA levels and the levels of nigral substance P and pallidal Met5-enkephalin depend on corticostriatal axons that use the excitatory amino acid neurotransmitters aspartate and glutamate: quantitative radioimmunocytochemical and in situ hybridization evidence.
    Somers DL; Beckstead RM
    Brain Res Mol Brain Res; 1990 Jul; 8(2):143-58. PubMed ID: 1698246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.